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Abstract 
Background: The differential susceptibly hypothesis suggests that certain genetic variants 
moderate the effects of both negative and positive environments on mental health and may 
therefore be important predictors of response to psychological treatments. Nevertheless, 
the identification of such variants has so far been limited to preselected candidate genes. In 
this study we extended the differential susceptibility hypothesis from a candidate gene to a 
genome-wide approach to test whether a polygenic score of environmental sensitivity 
predicted response to Cognitive Behavioural Therapy (CBT) in children with anxiety 
disorders.  
Methods: We identified variants associated with environmental sensitivity using a novel 
method in which within-pair variability in emotional problems in 1026 monozygotic (MZ) 
twin pairs was examined as a function of the pairs’ genotype. We created a polygenic score 
of environmental sensitivity based on the whole-genome findings and tested the score as a 
moderator of parenting on emotional problems in 1,406 children and response to individual, 
group and brief parent-led CBT in 973 children with anxiety disorders. 
Results: The polygenic score significantly moderated the effects of parenting on emotional 
problems and the effects of treatment. Individuals with a high score responded significantly 
better to individual CBT than group CBT or brief parent-led CBT (remission rates: 70.9%, 
55.5% and 41.6% respectively). 
Conclusions: Pending successful replication, our results should be considered exploratory. 
Nevertheless, if replicated, they suggest that individuals with the greatest environmental 
sensitivity may be more likely to develop emotional problems in adverse environments, but 
also benefit more from the most intensive types of treatment. 
 
 
Introduction 
Anxiety disorders are by far the most prevalent mental disorder and amongst the earliest to 
emerge, with the vast majority of adult cases beginning in childhood or adolescence [1]. 
While there is a substantial evidence base for the efficacy of psychological treatments for 
anxiety in children, response to treatment varies substantially between patients [2]. This 
means that identifying an effective treatment can be a long and costly process of trial and 
error that may both delay recovery and have a negative effect on long-term outcome. 
Genetic predictors of treatment response may allow clinicians to select the most effective 
treatment for a given individual at the outset, enhancing outcomes and accelerating 
recovery times [3]. Such predictors could also offer valuable insights into the mechanisms 
underlying response to psychological treatments [4]. 
The “differential susceptibility hypothesis” suggests that genetic factors moderate 
the effects of both negative and positive environments on mental health: for better and for 
worse [5]. In line with this hypothesis, individuals with one or two copies of the short allele 
of the 5-HTTLPR have been shown to be at a greater risk of mood disorders following 
adversity than individuals homozygous for the long allele [6]. However, these same 
individuals also benefit more from positive environmental influences such as supportive 
parenting [7], positive life events [8], or social support [9]. Importantly, these associations 
have also been shown to extend to moderation of the positive effects of various 
interventions including psychosocial training on depression [10], high-quality foster care on 
disturbances of attachment [11] and externalizing behaviour [12], and the efficacy of 
Cognitive Behavioural Therapy (CBT) in children with anxiety disorders [13]. In addition to 
findings from the 5-HTTLPR, differential susceptibility has been reported for a small number 
of further markers [14] with results from intervention studies showing particular promise 
[15]. Nevertheless, findings have failed to replicate, even in high quality studies, with very 
similar methodologies [16] [17]. While the causes of non-replication are unclear, one 
explanation is that environmental responsivity is a complex, polygenic trait, which is the 
result of multiple genetic variants of small effect, rather than a few select candidate genes.   
Gene-environment interaction research therefore needs to move from a candidate 
gene to genome-wide methodology, which takes into account the aggregate effects of 
multiple variants [18].  
Polygenic scoring allows the effects of multiple variants to be summarized in a single score. 
Specifically, alleles associated with a trait in a discovery sample at a given p value threshold 
are selected in an independent validation sample, and a score (the sum of these alleles 
weighted by their effect size) created for each individual [19]. Using this approach, a recent 
study reported that a polygenic score calculated using the results of a large case-control 
study of major depression moderated the effects of childhood maltreatment on depression 
in a further sample, with the interaction explaining a further 0.5% of the variance [20]. This 
approach to whole genome gene-environment interaction relies on the assumption that 
genetic variants have a main effect on outcome. This means that while this method may be 
suitable for detecting variants implicated in diathesis-stress interactions, it may not detect 
those involved in differential susceptibility, which are proposed to have no main effects [5]. 
One means of targeting these variants, is to explore genetic effects on intra-pair variability in 
outcomes in monozygotic (MZ) twin pairs. As they are genetically identical and share the 
same environment, discordance within MZ twin pairs on a measured outcome is considered 
to be the result of non-shared environmental effects. However, twin pairs with variants 
associated with increased sensitivity to the environment may have a greater intra-pair 
variability in outcome due to their increased responsivity to unmeasured non-shared 
environmental influences [21]. While this method has been previously used in a genome-
wide study of metabolism [22], it is yet to be applied to analyses of mental health outcomes. 
Moreover, this approach is yet to incorporate polygenic scoring to consider of the aggregate 
effects of variants associated with environmental sensitivity.  
In this study we aimed, for the first time, to test the differential susceptibility 
hypothesis using a genome-wide approach. First, we examined associations between genetic 
variants and intra-pair variability in emotional problems in MZ twins using genome-wide 
data. Next, in order to validate these findings, we calculated a polygenic score of sensitivity 
to the environment and tested whether this score moderated the effects of positive and 
negative parenting on emotional problems in a further sample of children. Finally, to test 
whether these same variants moderated response to psychological treatment, we tested the 
same polygenic environmental sensitivity score as a predictor of treatment response in a 
further clinical sample of children and adolescents with anxiety disorders treated with 
individual CBT, group CBT or brief parent-led CBT.  
In addition to examining an effect of the polygenic environmental sensitivity score 
on overall treatment response, we also explored whether the polygenic score predicted 
differential response to the different types of treatment received. The effect of 
environmental sensitivity on response to psychological treatments with differing intensities 
remains unknown. It has been suggested that those with a low sensitivity to the 
environment may require a more intensive type of treatment to achieve the same results as 
those who are highly sensitive. In this case, individuals with a low sensitivity would respond 
better to individual CBT than brief parent-led CBT.  Conversely, it has also been argued that 
individuals with a high sensitivity to the environment may benefit the most from more 
intensive forms of treatment. In this case individuals with a high sensitivity would respond 
more favourably to individual CBT, compared with lower intensity treatments such as brief 
parent-led CBT. 
 
  
Methods 
Samples 
This study utilized three samples: a discovery sample, a validation sample and a treatment 
response sample.  
 
Discovery and validation samples 
The discovery and validation samples were both drawn from the Twins Early Development 
Study (TEDS). TEDS is an ongoing longitudinal study of more than 11,000 twin pairs born in 
England and Wales in 1994, 1995, and 1996, which has been shown to be representative of 
the UK population [23]. The discovery sample included 1026 monozygotic twin pairs from 
TEDS for whom genome-wide genotyping data were available, as well as data on emotional 
problems at age 12. The validation sample included a further 1,409 unrelated individuals 
from TEDS (a randomly selected individual from the remaining dizygotic twins pairs) with 
available data. 
 
Measures 
Emotional problems were measured in the discovery and validation samples at age 12 using 
the emotional symptoms subscale of the Strengths and Difficulties Questionnaire [24]. We 
created a composite score by summing the z scores from child and parent reports and 
dividing by two. Parenting was assessed at age 12 in the validation sample using two child-
report measures: the Parental Feelings Questionnaire (PFQ) [25] and the Parental Strategies 
Questionnaire [26]. The PFQ includes 7 statements on the relationship with their parent on a 
3-point scale (very true, quite true, not true). The measure included four negative items (e.g. 
“I make my parents angry”) and three positive (e.g. “I feel happy about my relationship with 
my parents”). Positive items were reversed so that the total score reflected parental 
negativity. The Parental Strategies Questionnaire included four items in which children were 
asked to rate on a 3 point scale (rarely/never, sometimes, and often) what their parent did if 
they misbehaved including two positive  (e.g., “Explain or reason with me”) and two 
negative (e.g., “They give me a smack”) items. Positive items were reversed so that the total 
score reflected a more negative discipline strategy. An overall parenting score was created 
by summing the standardised scores from both scales. Separate positive and negative 
parenting scores were created by selecting the positive and negative items from each scale 
as reported previously in the TEDS data [27].  
 
Genetic data and quality control 
Both the discovery and validation samples were genotyped as part of the larger TEDS study. 
Full details of genotyping and quality control are provided elsewhere [28]. In brief, DNA was 
extracted from buccal cheek swabs samples and genotyped using Affymetrix GeneChip 6.0 
SNP genotyping arrays. Individuals were removed for a low call rate or excessive 
heterozygosity, atypical population ancestry, relatedness or sample duplication and gender 
mismatches. SNPs were excluded if they had a call rate less than 98%, minor allele frequency 
less than 1% or a Hardy Weinberg p-value lower than 1x10-20. Following quality control 
679,050 SNPs remained for analysis. 
 
The treatment response sample  
The treatment response sample was drawn from the Genes for Treatment (GxT) study, a 
multi-site collaboration, including 1,519 individuals, which was designed to examine genetic 
and clinical predictors of response to psychological treatments in pediatric anxiety disorders. 
Full details of the sample are available elsewhere [29]. In brief, participants were included if 
they were aged 5-18 years (94% were 5-13 years old), met DSM-IV criteria for a primary 
diagnosis of an anxiety disorder and provided DNA. Parents provided written consent and 
children written or verbal assent. All sites administered the Anxiety Disorders Interview 
Schedule for DSM-IV, Parent and Child Versions (ADIS-IV-C/P:[30]) except in two sites where 
the German equivalent, Kinder-DIPS, was used [31]. Participants were assessed before and 
immediately after treatment (post-treatment), with further assessments made 3, 6, or 12 
months after treatment cessation where possible (follow-up). The severity of the primary 
anxiety disorder was measured at each time-point using the Clinicians Severity Rating (CSR) 
from the structured interview, which assigns a score of 0-8 (absent to very severe). A 
diagnosis was made when the child met the diagnostic criteria and received a CSR of 4 or 
more. Ten sites (n=1,396) also assessed comorbid mood (major depression or dysthymia) or 
externalizing disorders (oppositional defiant disorder, conduct disorder or attention-
deficit/hyperactivity disorder [ADHD]) at baseline using the ADIS-C/P. All assessments were 
completed by graduate assistants or clinical staff (mainly psychologists) trained in the 
administration of the instruments. Sites have previously reported good inter-rater reliability 
for the diagnostic instruments using these samples [32-34]. In eight sites (n=1,289), parents 
also completed the Depression Anxiety Stress Scales (DASS) [35], assessing depression, 
anxiety, and stress symptoms experienced over the past week. For this study, the 3 
subscales were summed to create an overall measure of parental psychopathology. 
Of the 980 participants with available genome-wide genotyping data and at least 
one post baseline assessment, 269 (27.5%) were treated with individual CBT, 503 (51.3%) 
with group-based CBT, 201 (21.2%) with brief parent-led CBT and 7 (0.7%) with guided self-
help CBT. In order to limit the heterogeneity of the sample and aid interpretation of 
treatment specific effects, individuals treated with guided self-help CBT were excluded from 
the analysis. For the remaining 973 participants, (female: 54.9%, mean age: 9.8, SD=2.2), 
primary diagnoses included Generalised Anxiety Disorder (GAD; n=362, 37.2%), Social 
Anxiety Disorder (SoAD; n=201, 20.7%), Specific Phobia (SP; n=106, 10.9%), Separation 
Anxiety Disorder (SAD; n=223; 22.9%). The remaining participants (n=81, 8.3) were grouped 
as “other” anxiety disorders which included panic disorder with and without agoraphobia 
and agoraphobia without panic disorder (n = 26), obsessive-compulsive disorder (OCD; n = 
34), posttraumatic stress disorder (PTSD; n = 13), selective mutism (in patients with primary 
selective mutism, a diagnosis of severe SoAD was also given; the selective mutism was 
considered by the clinician to be primary, the most interfering: n = 2) or anxiety disorder not 
otherwise specified (n = 6).  
 
Genetic data and quality control 
Genotyping and quality control procedures for the GxT study are documented elsewhere 
[36]. In brief, DNA was extracted from buccal swabs and saliva and genotyped on the 
Illumina Human Core Exome-12v1.0 microarrays. Individuals with a call rate <99% or 
excessive heterozygosity were removed, as well as those with gender mismatches or 
evidence for relatedness or sample duplication. SNPs were excluded if they had a call rate 
less than 99%, minor allele frequency of less than 5% or had a Hardy Weinberg p-value lower 
than 1x10-5. Quality-controlled data was imputed to the December 2013 release of the 1000 
using IMPUTE2. Only SNPs with an info metric >0.8, and with a minor allele frequency (MAF) 
>1% were retained for analysis.  
 
Analyses 
Discovery sample 
Discordance in emotional symptom score was calculated as the absolute difference in scores 
between members of the pair. The effects of age, sex and the twin pair’s mean score in 
emotional symptoms were regressed out to create a residual score, which was then included 
as an outcome variable in a linear regression in PLINK. In order to control for possible effects 
of population stratification, we included the first 10 principal components from previous 
analyses of the TEDS data [28] as covariates in all analyses.  
 
Validation sample 
In the validation sample we aimed to test whether the environmental sensitivity polygenic 
score moderated the effects of parenting on emotional problems. Polygenic scores were 
calculated for each individual in the sample using the betas and p values from the discovery 
sample.  
We used increasingly liberal significance thresholds to select 8 sets of SNPs from the 
discovery sample that reached P<0.001, 0.01, 0.05, 0.1, 0.2, 0.3, 0.4 and 0.5. Prior to 
inclusion, SNPs were pruned for linkage disequilibrium using p-value informed clumping in 
PLINK employing cut offs of LD (r2= 0.25) and distance (a 200kb window).  
As in the discovery sample, we created a standardised age and sex regressed 
residual score of emotional symptoms for individuals in the validation sample. We explored 
the main effects of the polygenic environmental sensitivity score and parenting on this 
outcome using linear regressions. Next, we tested whether the polygenic score moderated 
the effects of parenting on emotional problems by testing a polygenic score by parenting 
interaction term in these models. The presence of a gene-environment correlation (i.e. an 
effect of the polygenic score on parenting) could potentially bias any polygenic score by 
parenting interactions. We therefore also tested whether our measures of parenting were 
associated with the polygenic score using linear regressions. We included socio-economic 
status (SES) as a covariate, as well as the first 10 principal components previously derived 
from genome wide analyses of the TEDS data [28] in order to account for any population 
stratification effects.  
 
Treatment response sample  
In the treatment response sample, we aimed to test whether the polygenic environmental 
sensitivity score predicted response to psychological treatments. We defined treatment 
response in the GxT sample as the change in severity (CSR score) of the primary anxiety 
diagnosis from baseline to each time-point in the study including measurements from the 
post-treatment, 3, 6 and 12 month time points. In order to include all of the available 
outcome data simultaneously, and provide estimates in the presence of missing values, we 
used a linear mixed model fitted with full maximum likelihood.  
We constructed a model including the fixed effects of baseline severity (CSR score of 
the primary diagnosis at baseline, centred at the mean) and the linear and quadratic effects 
of time to account for the curvilinear slope of treatment outcome. To account for 
correlations between repeated measures from the same subject all models included the 
random effects of individual. We also included a higher order random effect of trial to 
account for between trial differences. As in previous analyses, we covaried for clinical and 
demographic covariates including age, sex, primary diagnosis and treatment type by 
including these as fixed effects. We also included the first 10 principal components 
generated from previous genome wide analyses of the GxT data to account for confounding 
caused by population stratification. 
A polygenic environmental sensitivity score was calculated for each individual in the 
GxT sample using the same approach as in the validation sample and entered into the above 
model as a fixed effect. First, we tested the effects of the polygenic score on overall 
treatment response. Next, we tested treatment specific effects by examining the effects of 
the polygenic score separately in participants treated with individual CBT, group CBT or brief 
parent-led CBT and by testing for treatment type by polygenic score interactions. 
 
  
 
Results 
Discovery analyses 
In total 1026 monozygotic twin pairs (56.9% female, Mean age: 11.28, SD=0.02) with 
available genome-wide genotyping data and data on emotional symptoms were included in 
the discovery analyses. None of the included 679,050 SNPs reached genome-wide 
significance, nevertheless, several suggestively significant findings (P<1x10-5) were identified 
and are described in Table 1.  
 
Validation analyses 
The validation sample included 1,406 unrelated individuals with available data. The sample 
was significantly younger than the discovery sample (mean age = 11.20, SD=0.70; t=2.53, 
P=0.010) and included significantly fewer females (52.1%; χ2=5.33, P=0.021). However, 
individuals did not differ in their mean emotional symptoms scores (t=-1.50, P=0.133).  
All 679,050 SNPs from the discovery analysis passed quality control in the validation 
sample and following LD based pruning 155,019 SNPs remained to calculate the polygenic 
environmental sensitivity score in this sample. We generated 8 scores using increasingly 
liberal significance thresholds to select SNPs from the discovery sample (P<0.001, 0.01, 0.05, 
0.1, 0.2, 0.3, 0.4, 0.5) which included 400; 3,161; 13,632; 25,384; 46,752; 66,205; 84,025 and 
100,111 SNPs respectively. 
Table 2 shows the results of a linear regression exploring the main effects of each 
polygenic environmental sensitivity score and the main effects of parenting on emotional 
problems. The polygenic score was not significantly associated with emotional symptom 
score, and findings were consistent across all significance thresholds. There was a significant 
main effect of parenting on emotional problems in the expected direction, with more 
negative parenting associated with increased emotional symptom scores. In order to 
investigate whether the polygenic environmental sensitivity score moderated the effects of 
parenting on emotional problems we added an interaction term to the above models. 
Significant interactions were identified for polygenic scores calculated using 5 of the 8 P-
value thresholds. Interaction effects began to emerge when using a threshold of P<0.1 in the 
discovery sample where they explained an additional 0.33% of the variance. The addition of 
further SNPs strengthened these effects, which were greatest for the polygenic scores based 
on a threshold of P<0.5 where the interaction term explained an additional 0.53% of the 
variance. The interaction from this model is illustrated in Figure 1 in which the polygenic 
score (based on a threshold of P<0.5) is divided into equal tertiles to represent low 
moderate and high scores, and parenting score is separated into equal tertiles to represent 
negative, moderate and positive parenting. Findings were in the expected direction. 
Specifically, for individuals with a low polygenic environmental sensitivity score, parenting 
had little effect on emotional problems. However, for those with a higher polygenic score, 
negative parenting was associated with an increased emotional symptom score, while 
positive parenting was associated decreased scores. 
To explore these interaction effects further, we re-analysed the data considering the 
effects of positive and negative aspects of parenting separately (Tables S1-S2). Findings were 
consistent with those from the above analyses. Specifically, in individuals with a higher 
polygenic score, negative parenting was associated with increased emotional problems, 
while positive parenting was associated with decreased emotional symptom scores. 
However, in those with a polygenic score neither positive nor negative parenting had an 
effect on emotional problems. There was no evidence for gene-environment correlation. 
That is, there was no significant association between the polygenic environmental sensitivity 
score at any of the measured thresholds and our measures of parenting (Table S3). Finally, 
to test whether the same interaction effects were observed across raters, we reanalyzed the 
data, using child reported emotional problems and parent reported parenting. Findings were 
similar to those from our initial analysis showing significant interaction effects, which 
emerged when using a threshold of P<0.2 (Table S4). 
 
Treatment response analyses 
We used a linear mixed model to identify predictors of response (change in the severity of 
the primary diagnosis). Initially we explored the effects of clinical and demographic factors 
and findings were similar to those reported for the full sample [29]. Specifically, individuals 
with Social Anxiety Disorder (SoAD) or Specific Phobia (SP) showed a significantly poorer 
response to treatment than those with Generalized Anxiety Disorder (GAD), (β=0.43, 
P<0.001 and β=0.19, P=0.013) respectively. However, treatment response did not differ 
according to any other factors including sex, age or treatment-type (all P values > 0.05).  
In total 277,893 SNPs from the discovery analysis were available in the treatment 
response sample and following LD based pruning 72,375 remained to calculate the polygenic 
environmental sensitivity score. We generated 8 scores using increasingly liberal significance 
thresholds to select SNPs from the discovery sample (P<0.001, 0.01, 0.05, 0.1, 0.2, 0.3, 0.4, 
0.5) which included 159; 1,295; 5,905; 10,988; 20,423; 29,461; 37,668 and 45,371 SNPs 
respectively.  
The polygenic score did not significantly predict overall response to treatment and 
results were consistent across the different thresholds used to calculate the score (See Table 
3). However, the polygenic score did have treatment-specific effects on response. 
Specifically, the score was positively associated with response to individual CBT and 
negatively associated with response to brief parent-led CBT. These effects only emerged 
when the polygenic score included SNPs reaching P<0.05 in the discovery sample. At this 
threshold, the polygenic score explained 1.55% of the variance of response to individual CBT 
and 4.80% of the variance of response to brief parent-led CBT. While the addition of further 
SNPs improved the P value of these associations for brief parent-led CBT, they did not 
substantially improve the variance explained.  
We further explored the treatment specific effects of the polygenic score on 
outcome by testing for treatment type by polygenic score interactions. These analyses 
showed that the polygenic score (based on SNPs reaching P<0.05 in the discovery sample) 
significantly moderated the effect of each treatment type on outcome (individual vs. group 
CBT x polygenic score interaction: β=-0.13, 95%CI=-0.24--0.02, P=0.02); individual vs. brief 
parent-led CBT x polygenic score interaction: β=-0.30, 95%CI=-0.42--0.17, P=3.1 x 10-6; group 
CBT vs. brief parent-led CBT x polygenic score interaction: β=-0.15, 95%CI=-0.26--0.04, 
P=0.007).  
For those with a low polygenic environmental sensitivity score, treatment type had 
little effect on outcome. However, those with a high polygenic score responded well to 
individual CBT, moderately to group CBT and poorly to brief parent-led CBT. These effects 
are illustrated in Figure 2, which shows the mean change in anxiety severity score between 
baseline and the post-treatment time-point by tertiles of low, moderate and high polygenic 
score (using the threshold of P<0.05). Figure 3, shows the percentage of individuals in 
remission at the post-treatment time point by tertiles of low, moderate and polygenic score. 
70.9% of individuals at the upper tertile of the score treated with individual CBT were in 
remission at the post-treatment time point. However, remission rates for those in the upper 
tertile of the score were only 55.5% in those treated with group CBT and 41.6% in those 
treated with brief parent-led CBT 
As all analyses included baseline anxiety severity, diagnosis, age and gender as 
covariates, these factors are unlikely to cofound the relationship between the polygenic 
score and treatment response. However, we previously showed that comorbid externalising 
and internalising disorders (measured in a subset of the sample (n=935), as well as parental 
psychopathology (measured in a smaller subset, n=816) were associated with treatment 
response. Linear and logistic regressions showed that the polygenic score was not 
significantly related to parental psychopathology or the presence of comorbid externalising 
disorders, but was significantly associated with a lower likelihood of comorbid internalising 
disorders at the majority of the polygenic score thresholds tested (See Table S5) 
In order to exclude the possibility that the presence of comorbid internalising 
disorders confounded the relationship between the polygenic scores and treatment 
response we therefore re-ran analyses controlling for this variable on the subsample in 
which they were available. Findings were similar to those from the main analysis (see Table 
S6).  
Finally, the non-random allocation of treatments meant that individuals in each 
treatment group differed on several clinical and demographic factors including baseline 
severity, diagnosis, age, parental psychopathology and comorbid externalising and 
internalising disorders (See Table S7). To ensure that interactions between the polygenic 
score and treatment type on outcome were not biased by these differences we used 
propensity score matching to restrict analyses to individuals across treatment types who 
were matched for baseline severity, age, diagnosis, comorbid externalising and internalising 
disorders and parental psychopathology (see supplementary methods). Using this reduced 
sample, interaction effects were of a similar magnitude to those reported for the main 
analyses (individual vs. brief parent-led CBT x polygenic score interaction: β=-0.28, 95%CI=-
0.46--0.09, P=0.003; group CBT vs. brief parent-led CBT x polygenic score interaction: β=-
0.15, 95%CI=--0.29--0.01, P=0.041) suggesting that they were not the result of measured 
differences between treatment types at baseline.  
 
  
Discussion 
The differential susceptibility hypothesis suggests that the same genetic variants moderate 
the effects of both positive and negative environments on mental health. While several 
candidate gene studies support this hypothesis, this was the first to find evidence for 
differential susceptibility using a genome-wide approach. We used an MZ differences design 
to detect variants that increase the effects of the environment on the development of 
emotional problems. Consistent with the differential susceptibility hypothesis, we found 
that a polygenic environmental sensitivity score based on these findings moderated the 
effects of both positive and negative parenting on emotional problems in a further sample of 
children. The same polygenic score also moderated response to different psychological 
treatments in children with anxiety disorders. 
 
Main findings 
We examined within-pair variability in emotional symptoms in monozygotic twins to detect 
genetic variants associated with increased sensitivity to the environment. None of our 
findings reached genome-wide significance. Nevertheless, suggestively significant findings 
were identified in a region containing UHMK1, the gene, which encodes the brain-enriched 
protein kinase KIS. Animal models suggest that UHMK1 is highly expressed in the brain, and 
knockdown of this gene the development of cortical neurons in culture [37]. In line with our 
findings, UHMK1 knockout mice display a distinct deficit in fear conditioning which is 
accompanied by a down regulation of genes implicated in the aetiology of anxiety and fear 
including multiple components of GABA A receptors[38].  
Consistent with our hypothesis,  a polygenic environmental sensitivity score based 
on the whole genome results significantly moderated the effects of parenting on emotional 
problems in an unrelated sample. In line with the differential susceptibility hypothesis, this 
interaction applied to both the positive and negative aspects of this environmental measure. 
That is, for individuals with low environmental sensitivity, parenting had little effect on 
emotional problems. In contrast, for those with high environmental sensitivity, negative 
parenting was associated with increased emotional problems, while positive parenting was 
associated with decreased emotional symptom scores. While statistically significant, the 
effects of the environmental sensitivity by environment interactions were very small, 
explaining at most an additional 0.53% of the variance in outcome. Nevertheless, these 
findings are comparable to those reported for the main effects of polygenic scores and 
polygenic score by environment interactions in a previous study of major depression [20]. 
The variance explained was also larger than that reported for the main effects of polygenic 
scores on depression symptoms in a population sample [39].   
While the polygenic environmental sensitivity score did not predict overall response 
to treatment it did significantly predict differential response to individual CBT, group CBT 
and brief parent-led CBT. Importantly, these findings were not confounded by measured 
baseline clinical or demographic characteristics or biased by measured differences between 
treatment groups. The effects of environmental sensitivity appeared to increase linearly 
with the intensity of the treatment delivered, such that those with the highest 
environmental sensitivity responded best to individual CBT, moderately to group CBT and 
poorly to brief parent-led CBT. In contrast, those with a low environmental sensitivity 
responded equally well to each treatment type. The variance explained by the polygenic 
score was modest (1.62% in to those treated with individual CBT and 5.77% in those treated 
with parent-led guided self help) but are nevertheless comparable to previous studies of 
treatment response using a polygenic approach [40].  
Previous studies have created cumulative scores of environmental sensitivity based 
on small sets of hypothesised differential susceptibility alleles and tested them as 
moderators of the environment [41] and predictors of treatment response [3]. However, this 
was the first to use an MZ differences or genome-wide approach to detect and weight alleles 
according to their effect on environmental sensitivity. Nevertheless, our findings are 
consistent with those of multiple candidate gene studies in which specific variants have 
been shown to enhance the effects of both negative and positive parenting on internalising 
and externalising phenotypes [14], response to CBT [13], and a range of interventions for 
internalizing and externalizing behaviour [15].  
Studies are yet to examine the effects of sensitivity to the environment on response 
to CBT of varying intensity. It has been argued that individuals with a low sensitivity to the 
environment may require a more intensive type of treatment to achieve the same results as 
those who are highly sensitive. Our findings do not support this hypothesis. Outcomes for 
those with a low sensitivity to the environment were the same, regardless of the intensity of 
the treatment provided. In those with a high environmental sensitivity, the intensity of 
treatment was positively correlated with outcome such that they derived the most benefit 
from the most intensive forms of treatment. This finding is in line with the differential 
susceptibility hypothesis, which suggests that increasing exposure to an environment 
(positive or negative) has a greater effect on environmentally sensitive than environmentally 
insensitive individuals.  
A more complete explanation may be that individuals with increased genetic 
sensitivity to the environment develop more of the cognitive biases underlying anxiety 
disorders (such as a bias towards threat [42]) and therefore require more intensive 
treatments to overcome these aberrant cognitions. A prospective longitudinal study with 
data both at the onset of illness and throughout treatment would be necessary to directly 
test this hypothesis. Such a design would allow for the investigation of aetiological factors 
[43], as well as the effects of the course of illness and disease progression [44].  
 
Implications 
If replicated our findings may have several important implications for understanding the 
aetiology of emotional problems and treatment response.  
 We found our polygenic environmental sensitivity score was only a significant 
moderator of parenting or treatment response when it included variants reaching thresholds 
of P<0.1 and P<0.05 respectively in the discovery dataset. This suggests that sensitivity to 
the environment, rather than being the result of the effects of a handful of candidate genes, 
is a polygenic trait, which is due to the aggregate effects of tens of thousands of variants of 
small effect. These polygenic effects may explain why previous studies of gene-environment 
interaction, which focus on a single candidate gene, often fail to replicate.  
A previous polygenic score study, which assumed a diathesis-stress model, 
suggested that around 0.5% of the variance in the liability of major depression is accounted 
for by gene-environment interaction [20]. We report that a similar amount of variance in the 
aetiology of emotional problems is accounted for by variants operating in a manner 
consistent with differential susceptibility. A significant role of such variants may explain why 
despite moderate estimates of heritability, attempts to identity the genetic variants 
responsible for child anxiety and depression have so far been unsuccessful [28]. They may 
also explain why SNP-level heritability estimates are also considerably lower than those 
predicted from twins, even within the same samples [45].  
Polygenic predictors of environmental sensitivity may allow for a more accurate 
identification of those who are at risk of developing disorders in the face of adversity, but 
also who would be the most likely to benefit from which treatments. Previous findings from 
the current sample suggested that treatment type had little overall effect on outcome [29]. 
Indeed, a recent meta-analysis reported that individual CBT or group CBT were as effective 
as lower intensity self-help approaches [2]. However, our results suggest that the efficacy of 
different treatment types differs markedly according to environmental sensitivity. These 
effects are potentially clinically meaningful, with remission rates at the upper tertile of the 
polygenic score of 70.9%, 55.1% and 40.6% for Individual CBT, group CBT and brief parent-
led CBT respectively. If replicated, our findings suggest that for those with a relatively low 
genetic sensitivity to the environment more cost-effective, lower intensity approaches are 
equally as effective as face-to-face treatment. More importantly, they also suggest response 
rates may be substantially improved by targeting those with an increased genetic sensitivity 
to the environment with the most intensive psychological therapies.  
 
Strengths and limitations 
It has been noted that there are two principal challenges facing gene-environment 
interaction research: the necessity to develop methods which include the whole genome 
and those which include and reliably measure the whole ‘environome’ of relevant 
environments [18]. By assessing the aggregate effects of genetic variants from across the 
genome on unmeasured non-shared environmental effects, the current study 
simultaneously addresses both of these challenges. Nevertheless, our findings should be 
interpreted in the light of several important limitations. 
First, while our discovery analyses used a large, well-characterized sample of MZ 
twins, it was only adequately powered (80%) to detect individual variants with moderate 
effects on environmental sensitivity at genome-wide significance (explaining more than 1% 
of the variance of the variance) [21]. Although our polygenic approach did not rely solely on 
genome-wide significant findings, the discovery, validation and treatment samples were 
smaller than recommended for polygenic score analyses, particularly when testing 
treatment specific effects [19]. Our findings should therefore be considered exploratory, 
pending replication in further, larger samples.  
Second, we aimed to identify genetic variants that moderated the effects of the 
non-shared environment on emotional problems. We chose to validate these findings by 
exploring the interaction between the score and child reported parenting as this is one of 
the most robust environmental predictors of child anxiety [46] and has been shown to be 
moderated by genetic factors in manner consistent with differential susceptibility [7]. We 
identified similar interactions in cross rater analyses (using parent rated parenting and child 
rated emotional problems) and the same variants also moderated the arguably more 
objectively measured environment of psychological treatment. However, it remains 
unknown whether these findings extend to more objectively measured environments such 
as observed parenting.  
Finally, our treatment response sample included children with anxiety disorders 
receiving a psychological treatment as part of a trial or treatment as usual in one of multiple 
studies [29]. The subsequent non-random allocations of treatments meant that treatment 
type was associated with several clinical and demographic characteristics at baseline. While 
additional analyses using propensity score matching allowed us to conclude that our findings 
were not biased by measured differences between treatment groups, we cannot exclude the 
possibility that individuals differed by unmeasured factors. Replication of our findings in a 
randomized trial comparing low and high intensity CBT is therefore necessary to fully 
exclude the effects of confounding by indication.   
 
Conclusion 
The limited power provided by the cohorts used in each stage of our study means that our 
results should be considered exploratory until successfully replicated in larger samples. 
Nevertheless, if replicated, our findings suggest that responsivity to the environment is the 
result of multiple genetic variants of small effect, rather than a few select candidate genes. 
We show that these variants moderated the effects of parenting on the development of 
emotional problems in children. The same variants also predicted differential response to 
psychological treatments, such that those with the greatest sensitivity to the environment 
appeared to benefit the most from more intensive types of treatment. In line with previous 
polygenic score studies, the gene-by-environment effects we identified explained a very 
small proportion of the variance (0.53%). However, the variance explained by gene-by-
treatment effects was larger (1-5%). The potential clinical utility of these findings warrants 
further investigation of these effects in patients receiving low and high intensity CBT. 
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Table 1. Associations with intra-pair differences in emotional problems in monozygotic twins 
reaching suggestive significance (P<1x10-5) 
 
Chromosome  SNP ID  Position Allele Beta P value Nearest Gene 
1 rs12131428 162426451 C 0.3885 2.10 x 10-7 UHMK1 
22 rs5748871 17603477 A -0.1915 1.63 x 10-6 CECR6 
19 rs7339483 24462409 G 0.3683 6.20 x 10-6 ZNF254 
5 rs3864261 72358254 A 0.2662 7.33 x 10-6 FCHO2 
8 rs10875469 142333425 T -0.2144 9.29 x 10-6 GPR20 
5 rs1392412 72362289 G 0.2631 9.41 x 10-6 FCHO2 
 
 
  
Table 2. Validation analyses: Linear regression examining the main effects of polygenic environmental sensitivity score and parenting and their 
interaction on emotional problems  
P value threshold 
Main effects of polygenic environmental 
sensitivity scorea 
Main effects of parentinga Polygenic environmental sensitivity score 
by parenting interactionb 
  β 95% CI P β 95% CI P β 95% CI P % R2 
0.001 -0.01  -0.04-0.05  0.869 0.21   0.17-0.25  4.43 x 10-22 -0.04  -0.08-0.01  0.107 0.05 
0.01 -0.01  -0.05-0.03  0.718 0.21   0.17-0.25  4.65 x 10-22 0.01  -0.05-0.04  0.848 0.01 
0.05 0.01  -0.03-0.05  0.615 0.21   0.17-0.25  4.54 x 10-22 0.04  -0.01-0.08  0.085 0.22 
0.1 0.02  -0.03-0.06  0.470 0.21   0.17-0.25  4.38 x 10-22 0.05   0.00-0.09  0.035 0.33 
0.2 0.01  -0.03-0.05  0.727 0.21   0.17-0.25  4.58 x 10-22 0.06   0.01-0.10  0.011 0.47 
0.3 -0.01  -0.05-0.04  0.787 0.21   0.17-0.25  4.60 x 10-22 0.06   0.01-0.10  0.012 0.46 
0.4 -0.01  -0.05-0.03  0.636 0.21   0.17-0.25  4.52 x 10-22 0.06   0.02-0.10  0.008 0.49 
0.5 -0.01  -0.05-0.03  0.640 0.21   0.17-0.25  4.49 x 10-22 0.06   0.02-0.10  0.005 0.53 
 
a models included the main effects of polygenic environmental sensitivity score and child-reported parenting on age and sex regressed combined 
child/adult rated emotional symptom score. b models included the main effects of polygenic environmental sensitivity score and child-reported 
parenting and their interaction on age and sex regressed combined child/adult rated emotional symptom score. To account for possible effects of 
population stratification all models also included the first 10 principal components previously derived from genome-wide analyses of the TEDS data.
Table 3. Treatment response analyses: Linear mixed model examining the effect of the polygenic environmental sensitivity score on treatment 
response (change in the severity of the primary anxiety disorder). 
P value 
threshold 
Overall response Response to individual CBT Response to group based CBT Response to brief parent-led CBT 
β 95% CI P % R2 β 95% CI P % R2 β 95% CI P % R2 β 95% CI P % R2 
0.001 0.01  -0.03-0.05  0.699 0.03 -0.01  -0.09-0.08  0.865 0.00 0.02  -0.04-0.08  0.482 0.08 0.04  -0.06-0.15  0.408 0.45 
0.01 0.02  -0.02-0.06  0.357 0.04 -0.08  -0.17-0.01  0.077 0.72 0.04  -0.02-0.10  0.182 0.23 0.07  -0.02-0.16  0.151 0.80 
0.05 0.03  -0.02-0.07  0.267 0.05 -0.12  -0.21--0.03  0.009 1.62 0.02  -0.04-0.08  0.456 0.10 0.18   0.09-0.27  6.97 x 10-5 4.80 
0.1 0.02  -0.02-0.07  0.339 0.03 -0.11  -0.19--0.02  0.014 1.50 0.01  -0.05-0.07  0.720 0.04 0.20   0.11-0.29  1.92 x 10-5 5.21 
0.2 0.02  -0.02-0.07  0.277 0.05 -0.09  -0.18--0.01  0.033 1.11 0.01  -0.05-0.07  0.841 0.03 0.21   0.12-0.30  6.14 x 10-5 5.77 
0.3 0.02  -0.03-0.06  0.420 0.02 -0.10  -0.18--0.01  0.022 1.23 0.01  -0.06-0.06  0.947 0.00 0.20   0.11-0.29  1.99 x 10-5 5.20 
0.4 0.02  -0.03-0.06  0.485 0.01 -0.10  -0.19--0.02  0.017 1.36 0.01  -0.06-0.06  0.971 0.01 0.19   0.10-0.28  5.78 x 10-5 4.81 
0.5 0.02  -0.03-0.06  0.471 0.01 -0.11  -0.19--0.02  0.014 1.44 0.01  -0.06-0.06  0.918 0.00 0.19   0.10-0.29  3.47 x 10-5 5.14 
Note. To account for data collected longitudinally, all models included the random effects of participant and the linear and quadratic effects of 
time. All models also included sex, age (centred), primary diagnosis (Generalised Anxiety Disorder (GAD) Social Anxiety Disorder (SoAD) Specific 
Phobia (SP) Separation Anxiety Disorder (SAD) or “Other anxiety” disorder) and treatment type (individual based CBT group based CBT or brief 
parent-led CBT). All models included the random effects of trial. Regression weights (β) significantly greater than zero indicate that this variable is 
associated with a poorer response following treatment.  
 
 
 
Figure 1. Effects of the polygenic environmental sensitivity score, parenting and their interaction on 
emotional problems 
 
Mean standardised emotional symptom score by tertiles of parenting (representing negative, 
moderate and positive parenting) and tertiles of the polygenic environmental sensitivity score (low, 
moderate and high, threshold = P<0.5). Error bars represent 1 standard error. 
 
 
  
Figure 2. Effects of the polygenic environmental sensitivity score on change in clinical severity rating 
score from baseline to the post-treatment time point 
 
Mean change in clinical severity rating from baseline to post-treatment for individuals treated with 
individual CBT, group CBT and brief parent-led CBT by tertiles of the polygenic environmental 
sensitivity score (low, moderate and high). Error bars represent 1 standard error. 
 
  
Figure 3 Effects of the polygenic environmental sensitivity score on the percentage of individuals in 
remission at the post-treatment time point  
 
Percentage of individuals in remission at the post treatment time point for individuals treated with 
individual CBT, group CBT and brief parent-led CBT by tertiles of the polygenic environmental 
sensitivity score (low moderate and high). Error bars represent 1 standard error.  
  
Supplementary methods  
Propensity score matching  
Propensity score matching was used to match individuals across treatment types based on 
sex, age, baseline severity, primary diagnosis, parental psychopathology, comorbid 
internalizing and externalizing disorders. This approach allowed us to create a propensity 
score of each individual being treated with individual CBT vs group CBT, individual CBT vs 
brief parent-led CBT and group CBT vs Brief parent-led CBT. For each comparison individuals 
in one treatment group were matched, using the propensity score, to an individual receiving 
the alternative treatment using nearest neighbour matching in the psmatch2 package for 
STATA[1]. A threshold difference in propensity score of 0.02 within each pair was imposed to 
restrict analysis to the best-matched pairs[2]. This approach resulted in matched pairs for 
individual CBT vs group CBT (n=136, mean difference in propensity score =0.002, se=0.0003) 
individual CBT vs brief parent-led CBT (n=105, 0.006, se=0.0006) and group CBT vs Brief 
parent-led CBT (n=169; mean difference in propensity scores= 0.012, se=0.0004). Table S10 
shows differences in sex, age, baseline severity, primary diagnosis, parental 
psychopathology, comorbid internalizing and externalizing disorders before and after 
matching. 
Table S1. Validation analyses: Linear regression examining the main effects of the polygenic environmental sensitivity score, positive aspects of parenting 
and their interaction on emotional problems   
P value threshold 
Main effects of the polygenic 
environmental sensitivity 
scorea 
Main effects of positive aspects of 
parenting a 
Polygenic environmental sensitivity score 
by positive aspects of parenting 
interactionb 
  β 95% CI P β 95% CI P β 95% CI P % R2 
0.001 0.01 -0.04-0.05 0.838 -0.09 -0.13--0.04 8.99 x 10-5 0.05 0.01-0.10 0.020 0.38 
0.01 -0.01 -0.05-0.04 0.755 -0.09 -0.13--0.04 8.98 x 10-5 0.03 -0.01-0.08 0.175 0.13 
0.05 0.01 -0.03-0.05 0.645 -0.09 -0.13--0.04 8.69 x 10-5 -0.01 -0.06-0.03 0.563 0.02 
0.1 0.02 -0.03-0.06 0.458 -0.09 -0.13--0.04 8.77 x 10-5 -0.02 -0.06-0.02 0.373 0.06 
0.2 0.01 -0.04-0.05 0.706 -0.09 -0.13--0.04 8.86 x 10-5 -0.04 -0.08-0.01 0.105 0.18 
0.3 -0.01 -0.05-0.04 0.789 -0.09 -0.13--0.04 8.78 x 10-5 -0.04 -0.08-0.00 0.068 0.23 
0.4 -0.01 -0.05-0.03 0.656 -0.09 -0.13--0.04 8.85 x 10-5 -0.04 -0.09--0.00 0.040 0.29 
0.5 -0.01 -0.05-0.03 0.677 -0.09 -0.13--0.04 8.86 x 10-5 -0.05 -0.09--0.00 0.031 0.32 
 
 
 
Table S2. Validation analyses: Linear regression examining the main effects of the polygenic environmental sensitivity score, negative aspects of parenting 
and their interaction on emotional problems   
P value threshold 
Main effects of the polygenic 
environmental sensitivity 
scorea 
Main effects of negative aspects of 
parentinga 
Polygenic environmental sensitivity score 
by negative aspects of parenting 
interactionb 
  β 95% CI P β 95% CI P β 95% CI P % R2 
0.001 0.01  -0.04-0.04  0.908 0.23   0.19-0.27  1.66 x 10-28 -0.01  -0.06-0.03  0.505 0.03 
0.01 -0.01  -0.05-0.03  0.684 0.23   0.19-0.27  2.12 x 10-28 0.01  -0.03-0.05  0.630 0.02 
0.05 0.01  -0.03-0.05  0.581 0.23   0.19-0.27  2.14 x 10-28 0.05   0.00-0.09  0.035 0.29 
0.1 0.02  -0.03-0.06  0.465 0.23   0.19-0.27  1.60 x 10-28 0.05   0.01-0.10  0.014 0.40 
0.2 0.01  -0.03-0.05  0.706 0.23   0.19-0.27  2.06 x 10-28 0.06   0.01-0.10  0.009 0.45 
0.3 0.01  -0.05-0.04  0.819 0.23   0.19-0.27  2.09 x 10-28 0.05   0.01-0.10  0.020 0.35 
0.4 -0.01  -0.05-0.03  0.631 0.23   0.19-0.27  2.02 x 10-28 0.05   0.01-0.10  0.021 0.35 
0.5 -0.01  -0.05-0.03  0.612 0.23   0.19-0.27  2.12 x 10-28 0.05   0.01-0.10  0.020 0.36 
 
 
 
 
Table S3. Validation analyses: Effects of the polygenic environmental sensitivity score on measures of parenting  
P value 
threshold 
Overall parenting  Positive aspects of parenting  Negative aspects of parenting  
β 95% CI P β 95% CI P β 95% CI P 
0.001 0.02 -0.07-0.11 0.629 -0.03 -0.11-0.06 0.507 0.01 -0.08-0.10 0.842 
0.01 0.01 -0.08-0.10 0.839 0.02 -0.07-0.10 0.717 0.02 -0.07-0.10 0.726 
0.05 0.01 -0.09-0.09 0.994 0.01 -0.08-0.09 0.849 0.01 -0.09-0.08 0.913 
0.1 0.02 -0.07-0.11 0.689 0.01 -0.09-0.08 0.958 0.02 -0.07-0.10 0.714 
0.2 0.02 -0.07-0.11 0.705 -0.01 -0.09-0.08 0.858 0.01 -0.07-0.10 0.769 
0.3 0.01 -0.08-0.10 0.892 -0.01 -0.09-0.08 0.884 0.01 -0.09-0.09 0.993 
0.4 0.01 -0.08-0.09 0.917 0.01 -0.08-0.09 0.950 0.01 -0.08-0.09 0.900 
0.5 0.01 -0.08-0.10 0.888 0.01 -0.08-0.09 0.910 0.01 -0.08-0.10 0.817 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S4. Validation analyses: Linear regression examining the main effects of the polygenic environmental sensitivity score, parent-reported parenting and 
their interaction on child-reported emotional problems  
 
P value threshold 
Main effects of the polygenic 
environmental sensitivity 
scorea 
Main effects of parentinga Polygenic environmental sensitivity score 
by parenting interactionb 
  β 95% CI P β 95% CI P β 95% CI P % R2 
0.001 0.01  -0.04-0.06  0.783 0.17   0.12-0.22  5.30 x 10-11 0.03  -0.02-0.08  0.279 0.08 
0.01 0.02  -0.03-0.07  0.345 0.17   0.12-0.22  4.74 x 10-11 0.03  -0.02-0.08  0.265 0.09 
0.05 0.05   0.00-0.10  0.038 0.17   0.12-0.22  3.62 x 10-11 0.04  -0.01-0.09  0.146 0.15 
0.1 0.05   0.00-0.11  0.035 0.17   0.12-0.22  4.22 x 10-11 0.05  -0.00-0.10  0.065 0.24 
0.2 0.05  -0.01-0.10  0.081 0.17   0.12-0.22  4.99 x 10-11 0.06   0.00-0.11  0.034 0.31 
0.3 0.03  -0.02-0.08  0.242 0.17   0.12-0.22  4.84 x 10-11 0.06   0.00-0.11  0.036 0.30 
0.4 0.03  -0.02-0.08  0.303 0.17   0.12-0.22  4.79 x 10-11 0.07   0.01-0.12  0.016 0.40 
0.5 0.03  -0.02-0.08  0.284 0.17   0.12-0.22  4.84 x 10-11 0.07   0.02-0.12  0.011 0.44 
 
 
 
 
 
 
Table S5. Associations between the polygenic environmental sensitivity score and parental psychopathology and comorbid internalising and externalising 
disorders 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
P value threshold 
Parental psychopathology Comorbid externalising disorders Comorbid internalising disorders 
β 95% CI P β 95% CI P β 95% CI P 
0.001 -0.53  -1.81-0.75  0.417 0.05  -0.12-0.22  0.557 0.01 -0.19-0.22 0.940 
0.01 -0.86  -2.13-0.41  0.182 -0.10  -0.27-0.07  0.241 -0.31 -0.52--0.10 0.003 
0.05 -0.69  -1.96-0.58  0.288 -0.07  -0.24-0.09  0.382 -0.38 -0.59--0.17 4.51 x 10-4 
0.1 -0.32  -1.61-0.97  0.627 -0.05  -0.22-0.11  0.539 -0.32 -0.52--0.11 0.004 
0.2 -0.05  -1.35-1.25  0.941 -0.04  -0.21-0.12  0.627 -0.24 -0.44--0.03 0.023 
0.3 -0.01  -1.30-1.28  0.988 -0.03  -0.20-0.13  0.682 -0.21 -0.41--0.00 0.044 
0.4 0.13  -1.17-1.42  0.848 -0.04  -0.20-0.13  0.647 -0.20 -0.40-0.00 0.053 
0.5 0.06  -1.24-1.36  0.926 -0.03  -0.20-0.14  0.727 -0.21 -0.41--0.01 0.044 
Table S6. Treatment response analyses: Linear mixed model examining the effects of the polygenic environmental sensitivity score on treatment response 
(change in the severity of the primary anxiety disorder) adjusting for comorbid internalising disorders 
P value 
threshold 
Overall response Response to individual CBT Response to group based CBT Response to brief parent-led CBT 
β 95% CI P % R2 β 95% CI P % R2 β 95% CI P % R2 β 95% CI P % R2 
0.001 0.01  -0.04-0.05  0.698 0.02 -0.05  -0.14-0.04  0.265 0.22 0.03  -0.03-0.09  0.283 0.17 0.05  -0.06-0.15  0.390 0.46 
0.01 0.03  -0.02-0.07  0.226 0.08 -0.09  -0.19--0.00  0.049 0.97 0.05  -0.01-0.11  0.089 0.38 0.08  -0.02-0.17  0.107 0.97 
0.05 0.04  -0.01-0.08  0.091 0.13 -0.11  -0.21--0.02  0.015 1.74 0.04  -0.02-0.10  0.234 0.24 0.19   0.10-0.28  2.72 x 10-5 5.21 
0.1 0.03  -0.01-0.08  0.157 0.08 -0.11  -0.20--0.02  0.016 1.65 0.02  -0.04-0.08  0.458 0.11 0.20   0.12-0.29  7.30 x 10-6 5.61 
0.2 0.03  -0.01-0.08  0.126 0.11 -0.08  -0.17-0.01  0.076 1.01 0.01  -0.05-0.08  0.633 0.07 0.21   0.12-0.31  3.61 x 10-6 5.95 
0.3 0.03  -0.02-0.07  0.233 0.06 -0.09  -0.17-0.00  0.052 1.18 0.01  -0.06-0.07  0.866 0.02 0.20   0.11-0.29  1.21 x 10-5 5.36 
0.4 0.03  -0.02-0.07  0.262 0.05 -0.09  -0.18--0.00  0.049 1.24 0.01  -0.05-0.07  0.824 0.03 0.19   0.10-0.29  3.63 x 10-5 4.96 
0.5 0.03  -0.02-0.07  0.245 0.05 -0.09  -0.18--0.00  0.047 1.26 0.01  -0.06-0.06  0.892 0.02 0.20   0.11-0.29  2.15 x 10-5 5.29 
Note. To account for data collected longitudinally, all models included the random effects of participant and the linear and quadratic effects of time. All 
models also included sex, age (centred), primary diagnosis (Generalised Anxiety Disorder (GAD) Social Anxiety Disorder (SoAD) Specific Phobia (SP) 
Separation Anxiety Disorder (SAD) or “Other anxiety” disorder) and treatment type (individual based CBT group based CBT or brief parent-led CBT) and the 
presence of comorbid internalising disorders. All models included the random effects of trial. Regression weights (β) significantly greater than zero indicate 
that this variable is associated with a poorer response following treatment.  
Table S7. Differences between treatment groups before and after propensity score matching 
 
 
 
 
 
 
 
  
 
Individual vs. Group Individual CBT vs. brief parent-led CBT Group CBT vs. Brief parent-led  CBT 
Unmatched Matched Unmatched Matched Unmatched Matched 
Β (95% CI) P Β (95% CI) P Β (95% CI) P Β (95% CI) P Β (95% CI) P Β (95% CI) P 
Severity of primary 
diagnosis at baseline 
0.39 (0.13-0.66) 0.004 -0.20 (-0.55-0.14) 0.249 -0.37 (-0.57--0.16) 0.001 -0.08 (-0.32-0.17) 0.544 0.82 (0.60-1.03) <0.001 -0.10 (-0.37-0.18) 0.499 
Sex                                 0.01 (-0.47-0.50) 0.959 0.54 (-0.05-1.12) 0.072 0.21 (-0.20-0.62) 0.322 0.16 (-0.33-0.66) 0.514 0.02 (-0.36-0.39) 0.933 0.17 (-0.27-0.61) 0.458 
Age                                 0.29 (0.14-0.44) <0.001 0.02 (-0.16-0.19) 0.858 0.11 (0.01-0.21) 0.032 -0.07 (-0.19-0.05) 0.272 0.13 (0.04-0.23) 0.008 -0.01 (-0.14-0.11) 0.829 
Primary diagnosis             
   GAD            
 
   SoAD 0.34 (-0.33-1.01) 0.316 0.03 (-0.76-0.82) 0.937 1.03 (0.46-1.60) <0.001 0.14 (-0.58-0.86) 0.701 -0.59 (-1.09--0.09) 0.021 0.25 (-0.34-0.84) 0.411 
   SP 0.99 (0.24-1.73) 0.010 -0.15 (-1.05-0.75) 0.738 1.95 (1.30-2.60) <0.001 -0.13 (-0.92-0.67) 0.757 -0.87 (-1.51--0.23) 0.008 0.11 (-0.63-0.85) 0.769 
   SAD 0.76 (0.10-1.42) 0.024 -0.13 (-0.89-0.64) 0.747 1.53 (0.96-2.09) <0.001 -0.20 (-0.91-0.50) 0.574 -0.70 (-1.21--0.20) 0.007 0.10 (-0.49-0.69) 0.748 
   Other 0.61 (-0.40-1.63) 0.236 -0.32 (-1.57-0.94) 0.620 0.80 (0.03-1.57) 0.043 -0.03 (-0.99-0.92) 0.945 -0.01 (-0.80-0.78) 0.980 0.40 (-0.51-1.30) 0.388 
Comorbidity             
   Mood disorder -0.03 (-0.86-0.79) 0.942 -0.18 (-1.14-0.77) 0.709 0.28 (-0.34-0.90) 0.374 0.37 (-0.45-1.19) 0.378 -0.23 (-0.88-0.42) 0.491 -0.23 (-1.06-0.60) 0.581 
   Externalising disorder 0.44 (-0.15-1.04) 0.144 0.11 (-0.58-0.81) 0.747 0.90 (0.41-1.40) <0.001 0.02 (-0.57-0.62) 0.936 -0.32 (-0.82-0.18) 0.205 0.35 (-0.22-0.93) 0.225 
Parental 
psychopathology  
0.56 (0.29-0.84) <0.001 -0.05 (-0.37-0.28) 0.777 0.25 (0.03-0.47) 0.023 -0.04 (-0.31-0.23) 0.769 0.35 (0.13-0.58) 0.002 -0.04 (-0.31-0.23) 0.763 
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